Publicaciones en colaboración con investigadores/as de Johns Hopkins University (3)

2019

  1. Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

    The Lancet Neurology, Vol. 18, Núm. 9, pp. 845-856

2015

  1. Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort the PESA (Progression of Early Subclinical Atherosclerosis) study

    Circulation, Vol. 131, Núm. 24, pp. 2104-2113

2013

  1. The progression and early detection of subclinical atherosclerosis (PESA) study: Rationale and design

    American Heart Journal, Vol. 166, Núm. 6, pp. 990-998